Gilles Gagnon - Net Worth and Insider Trading
Gilles Gagnon Net Worth
The estimated net worth of Gilles Gagnon is at least $164,320 dollars as of 2024-09-30. Gilles Gagnon is the Director of Cosciens Biopharma Inc and owns about 31,600 shares of Cosciens Biopharma Inc (TSX:CSCI) stock worth over $164,320. Details can be seen in Gilles Gagnon's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Gilles Gagnon has not made any transactions after 2020-01-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Gilles Gagnon
Gilles Gagnon Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Gilles Gagnon owns 1 companies in total, including Cosciens Biopharma Inc (TSX:CSCI) .
Click here to see the complete history of Gilles Gagnon’s form 4 insider trades.
Insider Ownership Summary of Gilles Gagnon
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TSX:CSCI | Cosciens Biopharma Inc | 2020-01-15 | Director |
Gilles Gagnon Latest Holdings Summary
Gilles Gagnon currently owns a total of 1 stock. Gilles Gagnon owns 31,600 shares of Cosciens Biopharma Inc (TSX:CSCI) as of January 15, 2020, with a value of $164,320.
Latest Holdings of Gilles Gagnon
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TSX:CSCI | Cosciens Biopharma Inc | 2020-01-15 | 31,600 | 5.20 | 164,320 |
Holding Weightings of Gilles Gagnon
Gilles Gagnon Form 4 Trading Tracker
According to the SEC Form 4 filings, Gilles Gagnon has made a total of 1 transactions in Cosciens Biopharma Inc (TSX:CSCI) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Cosciens Biopharma Inc is the acquisition of 1,274 shares on January 15, 2020, which cost Gilles Gagnon around $22,140.
Insider Trading History of Gilles Gagnon
- 1
Gilles Gagnon Trading Performance
GuruFocus tracks the stock performance after each of Gilles Gagnon's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Gilles Gagnon is -31.71%. GuruFocus also compares Gilles Gagnon's trading performance to market benchmark return within the same time period. The performance of stocks bought by Gilles Gagnon within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Gilles Gagnon's insider trading performs compared to the benchmark.
Performance of Gilles Gagnon
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -8.54 | | | | | |
| Relative Return to S&P 500(%) | -11.3 | | | | | |
Gilles Gagnon Ownership Network
Gilles Gagnon Owned Company Details
What does Cosciens Biopharma Inc do?
Who are the key executives at Cosciens Biopharma Inc?
Gilles Gagnon is the Director of Cosciens Biopharma Inc.
Cosciens Biopharma Inc (TSX:CSCI) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Cosciens Biopharma Inc (TSX:CSCI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cosciens Biopharma Inc (TSX:CSCI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Cosciens Biopharma Inc (TSX:CSCI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cosciens Biopharma Inc Insider Transactions
Gilles Gagnon Mailing Address
Above is the net worth, insider trading, and ownership report for Gilles Gagnon. Currently GuruFocus does not have mailing address information for Gilles Gagnon.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
